July 08, 2021
The EMPEROR-Preserved study investigated empagliflozin (Jardiance; Eli Lilly) for the treatment of heart failure with preserved ejection fraction.
June 29, 2021
An oral abstract presentation at the American Diabetes Association Virtual 81st Scientific Sessions highlighted a cardioprotective benefit of sodium-glucose co-transporter-2 inhibitors.
June 25, 2021
A poster presented at the American Diabetes Association Virtual 81st Scientific Sessions highlighted the effect of a physician-pharmacist collaborative management team in diabetes preventative care services.
June 22, 2021
Blood-brain barrier crossing medicines have shown memory benefits in elderly patients, according to a new analysis.
Community model for hypertension management drives increased access, better outcomes for patients.
May 17, 2021
Individuals with prediabetes may be at increased risk of suffering an adverse cardiovascular event.
March 16, 2021
A new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.
March 10, 2021
The study incorporated diverse populations to determine the association between diets with a high glycemic index and cardiovascular disease risk.
March 04, 2021
Hispanic and Latino adults have a high prevalence of cardiovascular risk factors, but many are receiving inadequate treatment.
March 03, 2021
The American Heart Association published a special issue to discuss current research in cardiovascular disease and outcomes in women.
